PSMA5
Proteasome subunit alpha type-5
Also known as: PSA5_HUMAN, ZETA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28066
- Gene
- PSMA5
- Ensembl
- ENSG00000143106
- Chromosome
- 1
- Canonical length
- 241 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the peptidase T1A family, that is a 20S core alpha subunit. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
241 residues, UniProt reviewed canonical sequence.
>P28066|PSMA5
1 MFLTRSEYDR GVNTFSPEGR LFQVEYAIEA IKLGSTAIGI QTSEGVCLAV EKRITSPLME
61 PSSIEKIVEI DAHIGCAMSG LIADAKTLID KARVETQNHW FTYNETMTVE SVTQAVSNLA
121 LQFGEEDADP GAMSRPFGVA LLFGGVDEKG PQLFHMDPSG TFVQCDARAI GSASEGAQSS
181 LQEVYHKSMT LKEAIKSSLI ILKQVMEEKL NATNIELATV QPGQNFHMFT KEELEEVIKD
241 ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMA5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- liver: 19 nTPM
- lymph node: 12 nTPM
- cerebral cortex: 11 nTPM
- kidney: 10 nTPM
- thyroid gland: 9.5 nTPM
- tonsil: 8.7 nTPM
Single-cell type
- megakaryocytes: 291 nCPM
- syncytiotrophoblasts: 288 nCPM
- cytotrophoblasts: 284 nCPM
- migrating cytotrophoblasts: 269 nCPM
- esophageal suprabasal cells: 251 nCPM
- esophageal basal cells: 237 nCPM
Immune cell
- T-reg: 11 nTPM
- basophil: 11 nTPM
- naive CD8 T-cell: 9.8 nTPM
- naive CD4 T-cell: 9.7 nTPM
- memory CD4 T-cell: 9 nTPM
- MAIT T-cell: 8.4 nTPM
Brain region
- cerebral cortex: 18 nTPM
- hippocampal formation: 15 nTPM
- white matter: 15 nTPM
- hypothalamus: 14 nTPM
- basal ganglia: 12 nTPM
- medulla oblongata: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.81
- DepMap mean gene effect
- -1.94
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSMA5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMA5 as an antibody target. Whether an autoantibody or antibody against PSMA5 could matter depends on whether native PSMA5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMA5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMA5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...